| Polyp (no. = 7) | Atrophy (no. = 3) | Hyperplasia (no. = 7) | Carcinoma (no. = 2) | Adenomyosis (no. = 5) | Test value | p value | Sig. | |
---|---|---|---|---|---|---|---|---|---|
Age (years) | Mean ± SD | 47.83 ± 4.40 | 44.00 ± 1.41 | 49.71 ± 3.90 | 52.50 ± 2.12 | 42.40 ± 5.32 | 3.290 | 0.036 | S |
Range | 40–52 | 43–45 | 45–55 | 51–54 | 37–50 | ||||
Hormonal (year) | Mean ± SD | 3.64 ± 1.65 | 2.33 ± 0.58 | 2.79 ± 0.70 | 3.75 ± 1.77 | 1.40 ± 0.42 | 3.438 | 0.028 | S |
Range | 1–5 | 2–3 | 2–4 | 2.5–5 | 1–2 | ||||
Atypical vaginal bleeding | No | 4 (57.14%) | 0 (0.0%) | 6 (85.71%) | 0 (0.0%) | 5 (100%) | 13.029 | 0.011 | S |
Yes | 3 (42.85%) | 3 (100%) | 1 (14.29%) | 2 (100.0%) | 0 (0.0%) | ||||
US-endo. thickness (mm) | Mean ± SD | 14.64 ± 1.49 | 7.0 ± 6.08 | 16.71 ± 2.20 | 27.50 ± 3.54 | 9.76 ± 1.00 | 23.356 | 0.000 | HS |
Range | 13–17 | 3–14 | 12.5–19 | 25–30 | 8.60–11 | ||||
US-endo. regular | No | 0 (00%) | 3 (100%) | 0 (0.0%) | 2 (100.0%) | 5(100%) | 6.507 | 0.164 | NS |
Yes | 7 (100.0%) | 0 (0.0%) | 7 (100.0%) | 0 (0.0%) | 0 (0.0%) |